Refine Search
(7)
(9)
(9)
(9)

Immunology

More than 65% of pipeline drugs are in early stages of development. Tumor necrosis factor, B lymphocyte antigen CD20 and nuclear receptor ROR gamma are some of the major targets under research for immunological diseases.

NEW Lung Transplant Rejection - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Lung Transplant Rejection - Pipeline Review, H1 2018’, provides an overview of the Lung Transplant Rejection pipeline landscape.

The report provides comprehensive information on the therapeutics under developmen...

Peanut Allergy - Pipeline Review, H1 2018

  • $2,000
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Peanut Allergy - Pipeline Review, H1 2018’, provides an overview of the Peanut Allergy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Peanut Allergy, ...

Kidney Transplant Rejection - Pipeline Review, H1 2018

  • $2,000
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Kidney Transplant Rejection - Pipeline Review, H1 2018’, provides an overview of the Kidney Transplant Rejection pipeline landscape.

The report provides comprehensive information on the therapeutics under develo...

Psoriasis - Pipeline Review, H1 2018

  • $2,500
  • March 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H1 2018’, provides an overview of the Psoriasis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Psoriasis, complete with a...

Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2018

  • $2,000
  • March 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2018’, provides an overview of the Graft Versus Host Disease (GVHD) pipeline landscape.

The report provides comprehensive information on the therapeutics un...

Liver Transplant Rejection - Pipeline Review, H1 2018

  • $2,000
  • March 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Liver Transplant Rejection - Pipeline Review, H1 2018’, provides an overview of the Liver Transplant Rejection pipeline landscape.

The report provides comprehensive information on the therapeutics under developm...

Bone Marrow Transplant Rejection - Pipeline Review, H1 2018

  • $2,000
  • February 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Bone Marrow Transplant Rejection - Pipeline Review, H1 2018’, provides an overview of the Bone Marrow Transplant Rejection pipeline landscape.

The report provides comprehensive information on the therapeutics un...

Rheumatoid Arthritis - Pipeline Review, H2 2017

  • $2,500
  • December 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H2 2017’, provides an overview of the Rheumatoid Arthritis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Rheu...

Systemic Lupus Erythematosus - Pipeline Review, H2 2017

  • $2,000
  • November 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Systemic Lupus Erythematosus - Pipeline Review, H2 2017’, provides an overview of the Systemic Lupus Erythematosus pipeline landscape.

The report provides comprehensive information on the therapeutics under deve...